Fairvalue-Calculator Fairvalue-Calculator
EN DE

Global Health Limited (GLH) Fair Value & Analysis

Healthcare · AU · Market cap A$3.4M

PriceA$0.0530
Fair ValueA$0.0726
Upside+37.0%
Quality95/100
Evidence: Low Range A$0.0514 – A$0.1044

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Global Health Limited (GLH) currently trades at A$0.0530, while our model-based Fair Value estimate is A$0.0726 — implying the stock looks roughly 37.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Global Health Limited provides digital health solutions for the healthcare industry in Australia. The company offers software as a service platform and software applications for electronic medical records, client management systems, patient administration systems, practice management systems, clinical records, secure messaging, patient engagement platforms, and consumer health records. It is also involved in the development, sale, and support of the application software for the healthcare sector; and development of system integration software that enables data to be exchanged within an enterprise. The company sells its products under the MasterCare, PrimaryClinic, HotHealth, ReferralNet, and Lifecard brands. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Global Health Limited (GLH) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0726 versus a price of A$0.0530 — about +37% (undervalued). Model-based estimate, not financial advice.
What is the fair value of GLH?
Our 21-model fair value for Global Health Limited is A$0.0726 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0530.
What is the quality score of GLH?
Global Health Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.